SCHEMBL23787535

SCHEMBL23787535

Nc1c(/N=N/c2c(Cl)cc(-c3cc(Cl)c(/N=N/c4c(N)c(S(=O)(=O)O)c5ccccc5c4N)c(Cl)c3)cc2Cl)c(N)c2ccccc2c1S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ APP P05067 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ SNCA P37840 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ SENP2 Q9HC62 6/20 0.40
▸ SENP1 Q9P0U3 6/20 0.40
▸ SUMO2 P61956 5/20 0.40
▸ SUMO1 P63165 5/20 0.40
▸ SENP7 Q9BQF6 5/20 0.40
▸ SENP3 Q9H4L4 4/20 0.39
▸ MPL P40238 4/20 0.37
▸ SLC7A11 Q9UPY5 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787569 0.91 MEN1 (0.41) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787568 0.87 ALDH1A1 (0.46) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787670 0.83 SENP2 (0.47) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787534 0.83 MEN1 (0.41) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787543 0.83 ALDH1A1 (0.45) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787695 0.81 ENPP2 (0.44) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787533 0.81 SENP2 (0.40) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787519 0.80 APP (0.67) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787727 0.80 APP (0.53) MEN1ALDH1A1APPMAPTTHRB
SCHEMBL23787571 0.80 APP (0.59) MEN1ALDH1A1APPMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 MEN1 2015/4885ALDH1A1 3745/4885APP 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback